Efficacy and safety of active negative pressure peritoneal therapy for reducing the systemic inflammatory response after damage control laparotomy (the Intra-peritoneal Vacuum Trial): study protocol for a randomized controlled trial

Trials

Andrew W Kirkpatrick¹  Paul Kubes⁶  Stacy G Ruddell⁴  Christine R Skinner⁴  Christopher J Doig⁴  Paul B McBeth²  Peter D Faris³  Zhengwen Xiao¹  Caroline Léger⁶  Corina Tiruta¹  Chad G Ball¹  Craig N Jenne⁶  Derek J Roberts⁵ 

[1] Regional Trauma Program, University of Calgary and the Foothills Medical Centre, 1403-29th Street Northwest, Calgary, Alberta, T2N 2T9, Canada;Division of Critical Care Medicine, Department of Medicine, University of British Columbia and St. Paul’s Hospital, 1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada;Alberta Health Services – Research Excellence Support Team, University of Calgary and the Foothills Medical Centre, South Tower, 1403-29th Street Northwest, Calgary, Alberta, T2N 2T9, Canada;Department of Critical Care Medicine, University of Calgary and the Foothills Medical Centre, Ground Floor McCaig Tower, 3134 Hospital Drive Northwest, Calgary, Alberta, T2N 5A1, Canada;Department of Community Health Sciences (Divisions of Epidemiology and Biostatistics), University of Calgary, TRW (Teaching, Research, and Wellness) Building, 3rd Floor, 3280 Hospital Drive Northwest, Calgary, Alberta, T2N 4Z6, Canada;Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, University of Calgary and the Foothills Medical Centre, Health Research Innovation Centre, 3280 Hospital Drive Northwest, Calgary, Alberta, T2N 4N1, Canada

关键词: Wounds and injuries;    Temporary abdominal closure;    Sepsis;    Randomized controlled trial;    Negative pressure wound therapy;    Inflammation;    Damage control laparotomy;    Abdominal injuries;   

Others  :  1093990
DOI  :  10.1186/1745-6215-14-141

 received in 2012-12-05, accepted in 2013-04-30,  发布年份 2013

【 摘 要 】

Background

Damage control laparotomy, or abbreviated initial laparotomy followed by temporary abdominal closure (TAC), intensive care unit resuscitation, and planned re-laparotomy, is frequently used to manage intra-abdominal bleeding and contamination among critically ill or injured adults. Animal data suggest that TAC techniques that employ negative pressure to the peritoneal cavity may reduce the systemic inflammatory response and associated organ injury. The primary objective of this study is to determine if use of a TAC dressing that affords active negative pressure peritoneal therapy, the ABThera Open Abdomen Negative Pressure Therapy System, reduces the extent of the systemic inflammatory response after damage control laparotomy for intra-abdominal sepsis or injury as compared to a commonly used TAC method that provides potentially less efficient peritoneal negative pressure, the Barker’s vacuum pack.

Methods/Design

The Intra-peritoneal Vacuum Trial will be a single-center, randomized controlled trial. Adults will be intraoperatively allocated to TAC with either the ABThera or Barker’s vacuum pack after the decision has been made by the attending surgeon to perform a damage control laparotomy. The study will use variable block size randomization. On study days 1, 2, 3, 7, and 28, blood will be collected. Whenever possible, peritoneal fluid will also be collected at these time points from the patient’s abdomen or TAC device. Luminex technology will be used to quantify the concentrations of 65 mediators relevant to the inflammatory response in peritoneal fluid and plasma. The primary endpoint is the difference in the plasma concentration of the pro-inflammatory cytokine IL-6 at 24 and 48 h after TAC dressing application. Secondary endpoints include the differential effects of these dressings on the systemic concentration of other pro-inflammatory cytokines, collective peritoneal and systemic inflammatory mediator profiles, postoperative fluid balance, intra-abdominal pressure, and several patient-important outcomes, including organ dysfunction measures and mortality.

Discussion

Results from this study will improve understanding of the effect of active negative pressure peritoneal therapy after damage control laparotomy on the inflammatory response. It will also gather necessary pilot information needed to inform design of a multicenter trial comparing clinical outcomes among patients randomized to TAC with the ABThera versus Barker’s vacuum pack.

Trial registration

ClinicalTrials.gov identifierhttp://www.clicaltrials.gov/ct2/show/NCT01355094 webcite

【 授权许可】

   
2013 Roberts et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997, 349:1269-1276.
• [2]Chow AW, Evans GA, Nathens AB, Ball CG, Hansen G, Harding GK, Kirkpatrick AW, Weiss K, Zhanel GG: Canadian practice guidelines for surgical intra-abdominal infections. Can J Infect Dis Med Microbiol 2010, 21:11-37.
• [3]Stelfox HT, Bobranska-Artiuch B, Nathens A, Straus SE: Quality indicators for evaluating trauma care: a scoping review. Arch Surg 2010, 145:286-295.
• [4]Nishijima DK, Simel DL, Wisner DH, Holmes JF: Does this adult patient have a blunt intra-abdominal injury? JAMA 2012, 307:1517-1527.
• [5]Chovanes J, Cannon JW, Nunez TC: The evolution of damage control surgery. Surg Clin North Am 2012, 92:859-875. vii-viii
• [6]Waibel BH, Rotondo MF: Damage control for intra-abdominal sepsis. Surg Clin North Am 2012, 92:243-257. vii
• [7]Stone HH, Strom PR, Mullins RJ: Management of the major coagulopathy with onset during laparotomy. Ann Surg 1983, 197:532-535.
• [8]Burch JM, Ortiz VB, Richardson RJ, Martin RR, Mattox KL, Jordan GL Jr: Abbreviated laparotomy and planned reoperation for critically injured patients. Ann Surg 1992, 215:476-483. discussion 483–484
• [9]Rotondo MF, Schwab CW, McGonigal MD, Phillips GR III, Fruchterman TM, Kauder DR, Latenser BA, Angood PA: ‘Damage control’: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 1993, 35:375-382. discussion 382–383
• [10]Roberts DJ, Zygun DA, Grendar J, Ball CG, Robertson HL, Ouellet JF, Cheatham ML, Kirkpatrick AW: Negative-pressure wound therapy for critically ill adults with open abdominal wounds: a systematic review. J Trauma Acute Care Surg 2012, 73:629-639.
• [11]Holzheimer RG, Schein M, Wittmann DH: Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. Arch Surg 1995, 130:1314-1319. discussion 1319–1320
• [12]Scheingraber S, Bauerfeind F, Bohme J, Dralle H: Limits of peritoneal cytokine measurements during abdominal lavage treatment for intraabdominal sepsis. Am J Surg 2001, 181:301-308.
• [13]Mayberry JC, Welker KJ, Goldman RK, Mullins RJ: Mechanism of acute ascites formation after trauma resuscitation. Arch Surg 2003, 138:773-776.
• [14]Fink MP, Delude RL: Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 2005, 21:177-196.
• [15]Ince C: The microcirculation is the motor of sepsis. Crit Care 2005, Suppl 4:S13-S19.
• [16]van Veen SQ, Meijers JC, Levi M, van Gulik TM, Boermeester MA: Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis. Shock 2007, 27:534-541.
• [17]el Zakaria R, Li N, Garrison RN: Mechanisms of direct peritoneal resuscitation-mediated splanchnic hyperperfusion following hemorrhagic shock. Shock 2007, 27:436-442.
• [18]Kubiak BD, Albert SP, Gatto LA, Snyder KP, Maier KG, Vieau CJ, Roy S, Nieman GF: Peritoneal negative pressure therapy prevents multiple organ injury in a chronic porcine sepsis and ischemia/reperfusion model. Shock 2010, 34:525-534.
• [19]Hendriks T, Bleichrodt RP, Lomme RM, De Man BM, van Goor H, Buyne OR: Peritoneal cytokines predict mortality after surgical treatment of secondary peritonitis in the rat. J Am Coll Surg 2010, 211:263-270.
• [20]Ravishankaran P, Shah AM, Bhat R: Correlation of interleukin-6, serum lactate, and C-reactive protein to inflammation, complication, and outcome during the surgical course of patients with acute abdomen. J Interferon Cytokine Res 2011, 31:685-690.
• [21]Li P, Xu Q, Ji Z, Gao Y, Zhang X, Duan Y, Guo Z, Zheng B, Guo X, Wu X: Comparison of surgical stress between laparoscopic and open appendectomy in children. J Pediatr Surg 2005, 40:1279-1283.
• [22]Roelofsen H, Alvarez-Llamas G, Dijkstra M, Breitling R, Havenga K, Bijzet J, Zandbergen W, de Vries MP, Ploeg RJ, Vonk RJ: Analyses of intricate kinetics of the serum proteome during and after colon surgery by protein expression time series. Proteomics 2007, 7:3219-3228.
• [23]Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke MG, Lopez MC, Klein MB, Gamelli RL, Gibran NS, Arnoldo B, Xu W, Zhang Y, Calvano SE, McDonald-Smith GP, Inflammation and Host Response to Injury Large-Scale Collaborative Research Program, et al: A genomic storm in critically injured humans. J Exp Med 2011, 208:2581-2590.
• [24]Liu T, Qian WJ, Gritsenko MA, Xiao W, Moldawer LL, Kaushal A, Monroe ME, Varnum SM, Moore RJ, Purvine SO, Maier RV, Davis RW, Tompkins RG, Camp DG III, Smith RD, Inflammation and the Host Response to Injury Large Scale Collaborative Research Programm: High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics 2006, 5:1899-1913.
• [25]Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 1989, 74:1704-1710.
• [26]Latifi SQ, O’Riordan MA, Levine AD, Stallion A: Persistent elevation of serum interleukin-6 in intraabdominal sepsis identifies those with prolonged length of stay. J Pediatr Surg 2004, 39:1548-1552.
• [27]Gletsu N, Lin E, Zhu JL, Khaitan L, Ramshaw BJ, Farmer PK, Ziegler TR, Papanicolaou DA, Smith CD: Increased plasma interleukin 6 concentrations and exaggerated adipose tissue interleukin 6 content in severely obese patients after operative trauma. Surgery 2006, 140:50-57.
• [28]Frangen TM, Bogdanski D, Schinkel C, Roetman B, Kalicke T, Muhr G, Koller M: Systemic IL-17 after severe injuries. Shock 2008, 29:462-467.
• [29]Zeilhofer HU, Schorr W: Role of interleukin-8 in neutrophil signaling. Curr Opin Hematol 2000, 7:178-182.
• [30]Bingold TM, Ziesche E, Scheller B, Sadik CD, Franck K, Just L, Sartorius S, Wahrmann M, Wissing H, Zwissler B, Pfeilschifter J, Muhl H: Interleukin-22 detected in patients with abdominal sepsis. Shock 2010, 34:337-340.
• [31]Rongione AJ, Kusske AM, Ashley SW, Reber HA, McFadden DW: Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis. J Surg Res 1997, 70:107-112.
• [32]van Berge Henegouwen MI, van der Poll T, van Deventer SJ, Gouma DJ: Peritoneal cytokine release after elective gastrointestinal surgery and postoperative complications. Am J Surg 1998, 175:311-316.
• [33]Kimura A, Ono S, Hiraki S, Takahata R, Tsujimoto H, Miyazaki H, Kinoshita M, Hatsuse K, Saitoh D, Hase K, Yamamoto J: The postoperative serum interleukin-15 concentration correlates with organ dysfunction and the prognosis of septic patients following emergency gastrointestinal surgery. J Surg Res 2012, 175:e83-e88.
• [34]Pappu R, Ramirez-Carrozzi V, Sambandam A: The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 2011, 134:8-16.
• [35]Freitas A, Alves-Filho JC, Victoni T, Secher T, Lemos HP, Sonego F, Cunha FQ, Ryffel B: IL-17 receptor signaling is required to control polymicrobial sepsis. J Immunol 2009, 182:7846-7854.
• [36]Alves-Filho JC, Sonego F, Souto FO, Freitas A, Verri WA Jr, Auxiliadora-Martins M, Basile-Filho A, McKenzie AN, Xu D, Cunha FQ, Liew FY: Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 2010, 16:708-712.
• [37]Dib M, Zhao X, Wang X, Andersson E, Drewsen G, Andersson R: Acute phase response in acute pancreatitis: a comparison with abdominal sepsis. Scand J Gastroenterol 2003, 38:1072-1077.
• [38]Brenner T, Hofer S, Rosenhagen C, Steppan J, Lichtenstern C, Weitz J, Bruckner T, Lukic IK, Martin E, Bierhaus A, Hoffmann U, Weigand MA: Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock. J Surg Res 2010, 164:e163-e171.
• [39]Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, Heumann D, Mannel D, Bucala R, Glauser MP: Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000, 6:164-170.
• [40]Reith HB, Mittelkotter U, Wagner R, Thiede A: Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med 2000, Suppl 2:S165-S169.
• [41]Cziupka K, Busemann A, Partecke LI, Potschke C, Rath M, Traeger T, Koerner P, von Bernstorff W, Kessler W, Diedrich S, Weiss FU, Maier S, Broker BM, Heidecke CD: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) improves the innate immune response and enhances survival in murine polymicrobial sepsis. Crit Care Med 2010, 38:2169-2174.
• [42]Wang S: TRAIL: a sword for killing tumors. Curr Med Chem 2010, 17:3309-3317.
• [43]McBeth PB, Leger C, Ball CG, Ouellet JF, Tiruta C, Laupland KB, Kubes P, Roberts DJ, Shahpori R, Kirkpatrick AW: Intra-abdominal hypertension and intra-abdominal sepsis: critical concepts and possibilities. Int J Intensive Care 2011, 18:10-19.
• [44]Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993, 119:771-778.
• [45]Roumen RM, Hendriks T, van der Ven-Jongekrijg J, Nieuwenhuijzen GA, Sauerwein RW, van der Meer JW, Goris RJ: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993, 218:769-776.
• [46]Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993, 103:565-575.
• [47]Svoboda P, Kantorova I, Ochmann J: Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma 1994, 36:336-340.
• [48]Pettila V, Hynninen M, Takkunen O, Kuusela P, Valtonen M: Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002, 28:1220-1225.
• [49]Spindler-Vesel A, Wraber B, Vovk I, Kompan L: Intestinal permeability and cytokine inflammatory response in multiply injured patients. J Interferon Cytokine Res 2006, 26:771-776.
• [50]Jawa RS, Anillo S, Huntoon K, Baumann H, Kulaylat M: Interleukin-6 in surgery, trauma, and critical care part II: clinical implications. J Intensive Care Med 2011, 26:73-87.
• [51]Quyn AJ, Johnston C, Hall D, Chambers A, Arapova N, Ogston S, Amin AI: The open abdomen and temporary abdominal closure systems–historical evolution and systematic review. Colorectal Dis 2012, 14:e429-e438.
• [52]Bee TK, Croce MA, Magnotti LJ, Zarzaur BL, Maish GO III, Minard G, Schroeppel TJ, Fabian TC: Temporary abdominal closure techniques: a prospective randomized trial comparing polyglactin 910 mesh and vacuum-assisted closure. J Trauma 2008, 65:337-342. discussion 342–344
• [53]Clinical guidelines for the management of the open abdomen with ABThera™ Open Abdomen Negative Pressure Therapy System for active abdominal therapy. [http://www.peritonealvac.com/ABThera%20Clinical%20Guidelines.pdf webcite]
• [54]Brock WB, Barker DE, Burns RP: Temporary closure of open abdominal wounds: the vacuum pack. Am Surg 1995, 61:30-35.
• [55]Smith LA, Barker DE, Chase CW, Somberg LB, Brock WB, Burns RP: Vacuum pack technique of temporary abdominal closure: a four-year experience. Am Surg 1997, 63:1102-1107. discussion 1107–1108
• [56]Barker DE, Kaufman HJ, Smith LA, Ciraulo DL, Richart CL, Burns RP: Vacuum pack technique of temporary abdominal closure: a 7-year experience with 112 patients. J Trauma 2000, 48:201-206. discussion 206–207
• [57]Schulz KF, Altman DG, Moher D, CONSORT Group: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials 2010, 11:32. BioMed Central Full Text
• [58]Sammons A, Delgado A, Cheatham ML: In-vitro pressure manifolding distribution evaluation of the ABThera Open Abdomen Negative Pressure Therapy System, V.A.C. Abdominal Derssing System, and Barker’s vacuum-pack technique, conducted under dynamic conditions. San Antonio, TX: [Abst P 078] Clinical Symposium on Advances in Skin & Wound Care; 2009.
• [59]Diaz JJ Jr, Cullinane DC, Dutton WD, Jerome R, Bagdonas R, Bilaniuk JW, Collier BR, Como JJ, Cumming J, Griffen M, Gunter OL, Kirby J, Lottenburg L, Mowery N, Riordan WP Jr, Martin N, Platz J, Stassen N, Winston ES: The management of the open abdomen in trauma and emergency general surgery: part 1-damage control. J Trauma 2010, 68:1425-1438.
• [60]Asensio JA, Petrone P, O’Shanahan G, Kuncir EJ: Managing exsanguination: what we know about damage control/bailout is not enough. Proc (Bayl Univ Med Cent) 2003, 16:294-296.
• [61]Ivatury RR, Malhotra AK: Damage Control. In Trauma: Emergency Resuscitation, Perioperative Anesthesia, Surgical Management. Edited by Wilson WC, Grande CM, Hoyt DB. New York, NY: Informa Healthcare USA, Inc; 2007:405-416.
• [62]Kaplan M, Banwell P, Orgill DP, Ivatury RR, Demetriades D, Moore FA, Miller P, Nicholas J, Henry S: Guidelines for the management of the open abdomen. Wounds-Compend Clin Res Pract 2005, Suppl:1-24.
• [63]Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
• [64]Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med 1996, 22:707-710.
• [65]Baker SP, O’Neill B, Haddon W Jr, Long WB: The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974, 14:187-196.
• [66]Linn S: The injury severity score–importance and uses. Ann Epidemiol 1995, 5:440-446.
• [67]Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care 2004, 8:R204-R212. BioMed Central Full Text
• [68]Cheatham ML, Malbrain ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppaniemi A, Olvera C, Ivatury R, D’Amours S, Wendon J, Hillman K, Wilmer A: Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. II. Recommendations. Intensive Care Med 2007, 33:951-962.
• [69]Dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL: Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 2005, 66:175-191.
• [70]Shah SK, Jimenez F, Walker PA, Aroom KR, Xue H, Feeley TD, Uray KS, Norbury KC, Stewart RH, Laine GA, Cox CS Jr: A novel mechanism for neutrophil priming in trauma: potential role of peritoneal fluid. Surgery 2010, 148:263-270.
• [71]Shah SK, Jimenez F, Walker PA, Xue H, Feeley TD, Uray KS, Norbury KC, Stewart RH, Laine GA, Cox CS Jr: Peritoneal fluid: a potential mechanism of systemic neutrophil priming in experimental intra-abdominal sepsis. Am J Surg 2012, 203:211-216.
• [72]Ouellet JF, Ball CG: Recurrent abdominal compartment syndrome induced by high negative pressure abdominal closure dressing. J Trauma 2011, 71:785-786.
• [73]Rao M, Burke D, Finan PJ, Sagar PM: The use of vacuum-assisted closure of abdominal wounds: a word of caution. Colorectal Dis 2007, 9:266-268.
• [74]Fischer JE: A cautionary note: the use of vacuum-assisted closure systems in the treatment of gastrointestinal cutaneous fistula may be associated with higher mortality from subsequent fistula development. Am J Surg 2008, 196:1-2.
• [75]Ware JH: Linear models for the analysis of longitudinal studies. Am Stat 1985, 39:95-101.
• [76]Laird NM, Donnelly C, Ware JH: Longitudinal studies with continuous responses. Stat Methods Med Res 1992, 1:225-247.
• [77]Liu G, Gould AL: Comparison of alternative strategies for analysis of longitudinal trials with dropouts. J Biopharm Stat 2002, 12:207-226.
• [78]Mallinckrodt CH, Clark WS, David SR: Accounting for dropout bias using mixed-effects models. J Biopharm Stat 2001, 11:9-21.
• [79]Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995, 57:289-300.
• [80]Newson R: Multiple-test procedures and smile plots. Stata J 2003, 3:109-132.
• [81]Newson RB: Frequentist q-values for multiple-test procedures. Stata J 2010, 10:568-584.
• [82]van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, Dutch Peritonitis Study Group: Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 2007, 298:865-872.
• [83]Opmeer BC, Boer KR, van Ruler O, Reitsma JB, Gooszen HG, de Graaf PW, Lamme B, Gerhards MF, Steller EP, Mahler CM, Obertop H, Gouma DJ, Bossuyt PM, de Borgie CA, Boermeester MA: Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trial. Crit Care 2010, 14:R97. BioMed Central Full Text